Paul Lockman, Ph.D., BSN, assistant vice president of Experimental Therapeutics in the West Virginia University School of Medicine Department of Pharmacology and Benedum Fellow and the Mylan Endowed Chair professor in the School of Pharmacy, has received notification of continued funding for the research project “Tumor Microenvironment-TME CoBRE.”
The National Institute of General Medical Sciences, a part of the National Institutes of Health, awarded $2,132,598 for the 2026 fiscal year, which represents year eight of the 10-year grant totaling $20,255,116.
The grant supports the Tumor Microenvironment (TME) Center of Biomedical Research Excellence at West Virginia University. The program focuses on understanding how the environment around tumors affects cancer growth, spread, and treatment. The program supports research across several types of cancer, while also providing mentoring, training, and research resources to help junior faculty build successful research careers. The program will strengthen cancer research at West Virginia University and help address the high cancer burden among the people of West Virginia, Appalachia, and the nation.